---
title: "12 Health Care Stocks Moving In Friday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295281809.md"
description: "In Friday's after-market session, several healthcare stocks moved significantly. Gainers included AbCellera Biologics (+8.2%), NextCure (+7.87%), and SILO Pharma (+7.09%), driven largely by recent Q2 earnings reports. Conversely, losers featured Silexion Therapeutics (-13.4%), Matinas BioPharma (-9.97%), and Icecure Medical (-8.77%). The session highlighted volatility among small-cap biotech firms following their financial disclosures."
datetime: "2026-08-07T21:05:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295281809.md)
  - [en](https://longbridge.com/en/news/295281809.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295281809.md)
---

# 12 Health Care Stocks Moving In Friday's After-Market Session

### Gainers

-   **AbCellera Biologics** (NASDAQ:ABCL) shares increased by 8.2% to $7.5 during Friday's after-market session. The company's market cap stands at $1.9 billion. As per the news, the Q2 earnings report came out 2 days ago.
-   **NextCure** (NASDAQ:NXTC) shares rose 7.87% to $6.3. The company's market cap stands at $22.7 million. The company's, Q2 earnings came out yesterday.
-   **SILO Pharma** (NASDAQ:SILO) stock increased by 7.09% to $4.0. The company's market cap stands at $5.2 million.
-   **BioRestorative Therapies** (NASDAQ:BRTX) shares moved upwards by 6.61% to $0.22. The market value of their outstanding shares is at $5.3 million.
-   **Akanda** (NASDAQ:AKAN) shares increased by 5.65% to $5.42. The market value of their outstanding shares is at $2.8 million.
-   **Vyome Holdings** (NASDAQ:HIND) shares moved upwards by 5.52% to $2.29. The company's market cap stands at $15.0 million.

### Losers

-   **Silexion Therapeutics** (NASDAQ:SLXN) shares declined by 13.4% to $1.62 during Friday's after-market session. The market value of their outstanding shares is at $1.9 million.
-   **Matinas BioPharma Hldgs** (AMEX:MTNB) shares fell 9.97% to $0.25. The company's market cap stands at $1.7 million.
-   **Icecure Medical** (NASDAQ:ICCM) shares declined by 8.77% to $2.81. The company's market cap stands at $10.5 million.
-   **NuCana** (NASDAQ:NCNA) stock decreased by 8.17% to $1.35. The company's market cap stands at $5.6 million.
-   **Radiopharm Theranostics** (NASDAQ:RADX) shares fell 7.15% to $2.6. The company's market cap stands at $21.7 million.
-   **Imunon** (NASDAQ:IMNN) shares declined by 6.84% to $1.5. The market value of their outstanding shares is at $6.6 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [ABCL.US](https://longbridge.com/en/quote/ABCL.US.md)
- [NXTC.US](https://longbridge.com/en/quote/NXTC.US.md)
- [SLXN.US](https://longbridge.com/en/quote/SLXN.US.md)
- [SILO.US](https://longbridge.com/en/quote/SILO.US.md)
- [ICCM.US](https://longbridge.com/en/quote/ICCM.US.md)
- [MTNB.US](https://longbridge.com/en/quote/MTNB.US.md)
- [BRTX.US](https://longbridge.com/en/quote/BRTX.US.md)
- [AKAN.US](https://longbridge.com/en/quote/AKAN.US.md)
- [HIND.US](https://longbridge.com/en/quote/HIND.US.md)
- [NCNA.US](https://longbridge.com/en/quote/NCNA.US.md)
- [RADX.US](https://longbridge.com/en/quote/RADX.US.md)
- [IMNN.US](https://longbridge.com/en/quote/IMNN.US.md)
- [SLXNW.US](https://longbridge.com/en/quote/SLXNW.US.md)

## Related News & Research

- [What's Going on With AbCellera Biologics Stock On Wednesday?](https://longbridge.com/en/news/295696830.md)
- [AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants | ABCL Stock News](https://longbridge.com/en/news/295741148.md)
- [09:10 ETIceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation](https://longbridge.com/en/news/295805121.md)
- [IceCure highlights 5-year ICE3 breast cancer trial showing 3.1% recurrence rate after cryoablation](https://longbridge.com/en/news/295804964.md)
- [BUZZ-AbCellera slips after launching $200 mln stock offering to fund menopause drug](https://longbridge.com/en/news/295575515.md)